SCHEMBL25002893

SCHEMBL25002893

CCOc1ccc(-c2cccc(C(=O)OC)n2)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.55
RAB9A P51151 3/20 0.55
SCN2A Q99250 3/20 0.50
SCN10A Q9Y5Y9 3/20 0.50
SCN9A Q15858 1/20 0.48
GRM5 P41594 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 2/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.46
MITF O75030 1/20 0.46
PKM P14618 1/20 0.46
FAAH O00519 1/20 0.46
CTSA P10619 1/20 0.46
MAPT P10636 2/20 0.46
POLB P06746 1/20 0.46
AHR P35869 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25002917 0.89 PLA2G2A (0.54) NPC1RAB9ASCN9AKDM4EALDH1A1
SCHEMBL25003937 0.89 PLA2G2A (0.58) NPC1RAB9ASCN9AKDM4EALDH1A1
SCHEMBL22940145 0.86 PLA2G2A (0.55) NPC1SMN1; SMN2LMNACYP1A2MAPT
SCHEMBL29660380 0.86 KDM4E (0.55) NPC1RAB9ASCN2ASCN10AADORA3
SCHEMBL22939955 0.86 ADORA3 (0.50) NPC1RAB9ASCN2ASCN10ASCN9A
SCHEMBL25002929 0.85 ADORA3 (0.52) NPC1RAB9ASCN10ASCN9AADORA3
SCHEMBL22939576 0.85 CYP1A2 (0.50) NPC1RAB9ASCN2ASCN10AADORA3
SCHEMBL25003805 0.85 ALDH1A1 (0.57) NPC1RAB9ASCN2ASCN10ASCN9A
SCHEMBL3129112 0.84 KDM4E (0.55) SCN9AKDM4EALDH1A1HPGDMAPT
SCHEMBL3712561 0.84 MCL1 (0.59) NPC1RAB9ASMN1; SMN2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 WO disclosed